Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop
-
Jou-Ku Chung , Vice President, Clinical Pharmacology and Translational Medicine atAstria Therapeutics , will present new human mechanistic modeling data in a poster titled “Mechanistic Modeling and Simulations Predict Long-Term HAE Attack Prevention with STAR-0215.” The poster session will take place onFriday May 5 , at2:00pm CEST . -
Dr.
Marcus Maurer , M.D., Professor of Dermatology and Allergy at Charité Universitätsmedizin inBerlin and Principal Investigator for the ALPHA-STAR trial, will present “Design of ALPHA-STAR, a Phase 1b/2 Proof-of-Concept Trial of STAR-0215 as a Long-Acting Preventative Therapy in Patients with Hereditary Angioedema (HAE) Types I or II” in an oral presentation onSaturday May 6 , at9:15am CEST .
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20230428005030/en/
Investor relations:
investors@astriatx.com
Media:
media@astriatx.com
Source: